arcadia

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2783.80-55 (-1.94 %)
PREV CLOSE ( ) 2838.80
OPEN PRICE ( ) 2835.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2783.80 (32)
VOLUME 1231
TODAY'S LOW / HIGH ( )2768.70 2855.00
52 WK LOW / HIGH ( )2040 2990
NSE2783.30-48.7 (-1.72 %)
PREV CLOSE( ) 2832.00
OPEN PRICE ( ) 2822.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2783.30 (120)
VOLUME 13931
TODAY'S LOW / HIGH( ) 2765.00 2859.85
52 WK LOW / HIGH ( )2020 2994.9
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 13-11 1924
Management Info
D S Parekh - Chairman A Vaidheesh - Managing Director
Registered Office

Address Dr Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com

Website www.gsk-india.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
28Jun Announcement under Regulation 30 (LOD
Pursuant to clause 47 of the Listing Obligations and Disclosure Requirem..
25May Board Meeting-Outcome of Board Meeting
we are pleased to furnish the following information: 1. Dividend The..
08May Announcement under Regulation 30 (LOD
Pursuant to clause 47 of the Listing Obligations and Disclosure Requirem..
30Apr Board to consider FY18 results & Divi
GlaxoSmithKline Pharmaceuticals Ltd has informed BSE that a meeting of t..
16Mar Glaxosmithkline Pharmaceuticals inform
Pursuant to Regulation 30 and Schedule III (A) (7) of the Listing and Di..
Financials
Rs. in Millions
QTR Mar 18 ANNUAL 18
Net Profit1055.53519.8
Gross Profit 1636.1 5415.8
Operating Profit 1731.65619.6
Net Sales 7486.228958.8
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 7179.55 (2.08%)
M.Cap ( in Cr)15256.04
Piramal Enterprises (BSE)
 2558.45 (1.31%)
M.Cap ( in Cr)46205.04
Astrazeneca Pharma I (BSE)
 1423.70 (1.71%)
M.Cap ( in Cr)3559.25
Pfizer (BSE)
 2571.10 (0.79%)
M.Cap ( in Cr)11762.20
Zim Laboratories (BSE)
 350.00 (4.48%)
M.Cap ( in Cr)282.09
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 12.43%
FI/BANKS/INSURANCE 8.32%
MUTUAL FUNDS/UTI 2.65%
FII 0%
GOVERNMENT 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM